|
|
|
| Application of Esketamine in Patients with Traumatic Severe Brain Injury and Analysis of Changes in Serum Neurofactor Levels |
| SHI Dongdong, LIAO Xingzhi, CHEN Tian, et al |
| The 904th Hospital of the Joint Logistics Support Forceof PLA, Jiangsu Wuxi 214000, China |
|
|
|
|
Abstract Objective: To explore the application of ketamine in patients with traumatic severe craniocerebral injury and analyze the changes in serum neurotrophic factor levels. Methods: A total of 180 patients with traumatic severe craniocerebral injury treated in our hospital from January 2020 to January 2023 were selected as the research objects and divided into two groups, with 90 cases in each group, according to the random number table method. The control group received single sufentanil drug treatment after surgery, while the study group received ketamine treatment based on the control group. The pain score, agitation score, cognitive function (MoCA scale), and changes in serum neurotrophic factors (BDNF, NGF) and inflammatory factors (hs-CRP, TNF-α, IL-6) at different time points were observed in both groups.Results: At 12h and 24h after administration, the pain scores and agitation scores in both groups were lower than before administration, and the scores in the study group were lower than those in the control group at 12h and 24h after administration. The MoCA scores in both groups decreased after administration, with the study group higher than the control group. Both BDNF and NGF levels increased after administration in both groups, with the study group higher than the control group. The levels of hs-CRP, TNF-α, and IL-6 decreased in both groups after administration, with the study group lower than the control group (P<0.05).Conclusion: The application of ketamine in patients with traumatic severe craniocerebral injury can effectively reduce pain and agitation scores, improve cognitive function, promote the generation of neurotrophic factors, and reduce the level of inflammatory factors.
|
|
|
|
|
|
[1] 王海燕,黄月伟,高特生.艾司氯胺酮诱导预防烧伤患者术后寒战的研究[J].浙江医学,2023,45(3):281-283.
[2] 王芬,郑曼,李莎,等.小剂量艾司氯胺酮联合右美托咪定在OSAHS患者清醒气管插管中的应用效果观察[J].山东医药,2023,63(5):59-62.
[3] 解飞,杜佳楠,徐夏.艾司氯胺酮联合舒芬太尼对腹腔镜结肠癌根治术后镇痛效果及血流动力学的影响[J].中国现代医学杂志,2023,33(2):19-24.
[4] 景建闯,刘鹏,安波.艾司氯胺酮调节Nrf2/HO-1信号通路对骨关节炎大鼠镇痛作用的研究[J].东南大学学报:医学版,2023,42(1):9-15.
[5] 魏中南,孙宁,马骁,等.FGF-19联合IFABP对儿童重型创伤性脑损伤合并胃肠功能障碍的诊断价值[J].中国实验诊断学,2021,25(9):1292-1296.
[6] 唐维婕,王丹丹,张玉.腹部按摩联合枯草杆菌二联活菌对重型创伤性脑损伤病人胃肠道排空作用的分析[J].现代医学,2022,50(6):769-772.
[7] 黄娥,杨燕,陆宝荣.基于主成分分析的回归模型用于重型创伤性脑损伤术后外伤性脑梗死护理评估价值[J].中国急救复苏与灾害医学杂志,2022,17(9):1234-1237.
[8] 晏筱莹,李世梅,江海霞.小剂量纳美芬减轻瑞芬太尼所致患者术后的痛觉敏化[J].昆明医科大学学报,2023,44(1):59-64. |
|
|
|
2024, Vol. 30 
